These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 22168244)

  • 1. Vaginal Health: Insights, Views & Attitudes (VIVA) - results from an international survey.
    Nappi RE; Kokot-Kierepa M
    Climacteric; 2012 Feb; 15(1):36-44. PubMed ID: 22168244
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vaginal Health: Insights, Views & Attitudes (VIVA-LATAM): results from a survey in Latin America.
    Nappi RE; de Melo NR; Martino M; Celis-González C; Villaseca P; Röhrich S; Palacios S
    Climacteric; 2018 Aug; 21(4):397-403. PubMed ID: 29741110
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Women's voices in the menopause: results from an international survey on vaginal atrophy.
    Nappi RE; Kokot-Kierepa M
    Maturitas; 2010 Nov; 67(3):233-8. PubMed ID: 20828948
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Women's preferences toward attributes of local estrogen therapy for the treatment of vaginal atrophy.
    Mattsson LÅ; Ericsson Å; Bøgelund M; Maamari R
    Maturitas; 2013 Mar; 74(3):259-63. PubMed ID: 23312488
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vaginal Health: Insights, Views & Attitudes survey in Latin America (VIVA-LATAM): focus on Brazil.
    Pompei LM; Wender MCO; de Melo NR; Kulak J; Pardini D; Machado RB; Fernandes CE; Palacios S; Nappi RE
    Climacteric; 2021 Apr; 24(2):157-163. PubMed ID: 32869682
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vaginal health in the United States: results from the Vaginal Health: Insights, Views & Attitudes survey.
    Simon JA; Kokot-Kierepa M; Goldstein J; Nappi RE
    Menopause; 2013 Oct; 20(10):1043-8. PubMed ID: 23571518
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The CLOSER (CLarifying Vaginal Atrophy's Impact On SEx and Relationships) survey: implications of vaginal discomfort in postmenopausal women and in male partners.
    Nappi RE; Kingsberg S; Maamari R; Simon J
    J Sex Med; 2013 Sep; 10(9):2232-41. PubMed ID: 23809691
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of symptomatic vulvovaginal atrophy: 2013 position statement of The North American Menopause Society.
    Menopause; 2013 Sep; 20(9):888-902; quiz 903-4. PubMed ID: 23985562
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Women's EMPOWER Survey: Women's Knowledge and Awareness of Treatment Options for Vulvar and Vaginal Atrophy Remains Inadequate.
    Krychman M; Graham S; Bernick B; Mirkin S; Kingsberg SA
    J Sex Med; 2017 Mar; 14(3):425-433. PubMed ID: 28202319
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Attitudes and approaches to vaginal atrophy in postmenopausal women: a focus group qualitative study.
    Utian WH; Maamari R
    Climacteric; 2014 Feb; 17(1):29-36. PubMed ID: 24083795
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Managing postmenopausal vaginal atrophy. Vaginal dryness is one of the most irritating symptoms of menopause. Here are some ways to relieve it.
    Harv Womens Health Watch; 2010 Mar; 17(7):4-5. PubMed ID: 20480969
    [No Abstract]   [Full Text] [Related]  

  • 12. The CLOSER survey: impact of postmenopausal vaginal discomfort on women and male partners in the UK.
    Domoney C; Currie H; Panay N; Maamari R; Nappi RE
    Menopause Int; 2013 Jun; 19(2):69-76. PubMed ID: 23778561
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vaginal Health: Insights, Views & Attitudes (VIVA) survey - Canadian cohort.
    Frank SM; Ziegler C; Kokot-Kierepa M; Maamari R; Nappi RE
    Menopause Int; 2013 Mar; 19(1):20-27. PubMed ID: 23201626
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The detection and management of vaginal atrophy.
    Johnston SL; Farrell SA; Bouchard C; Farrell SA; Beckerson LA; Comeau M; Johnston SL; Lefebvre G; Papaioannou A;
    J Obstet Gynaecol Can; 2004 May; 26(5):503-15. PubMed ID: 15151738
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of local vaginal estrogen for treatment of vaginal atrophy in postmenopausal women: 2007 position statement of The North American Menopause Society.
    North American Menopause Society
    Menopause; 2007; 14(3 Pt 1):355-69; quiz 370-1. PubMed ID: 17438512
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vulvar and vaginal atrophy in postmenopausal women: findings from the REVIVE (REal Women's VIews of Treatment Options for Menopausal Vaginal ChangEs) survey.
    Kingsberg SA; Wysocki S; Magnus L; Krychman ML
    J Sex Med; 2013 Jul; 10(7):1790-9. PubMed ID: 23679050
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Perceptions of dyspareunia in postmenopausal women with vulvar and vaginal atrophy: findings from the REVIVE survey.
    Freedman MA
    Womens Health (Lond); 2014 Jul; 10(4):445-54. PubMed ID: 25259904
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Association Between Vulvovaginal Atrophy Symptoms and Quality of Life Among Postmenopausal Women in the United States and Western Europe.
    DiBonaventura M; Luo X; Moffatt M; Bushmakin AG; Kumar M; Bobula J
    J Womens Health (Larchmt); 2015 Sep; 24(9):713-22. PubMed ID: 26199981
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Symptoms, attitudes and treatment perceptions of vulvo-vaginal atrophy in UK postmenopausal women: Results from the REVIVE-EU study.
    Domoney C; Short H; Particco M; Panay N
    Post Reprod Health; 2020 Jun; 26(2):101-109. PubMed ID: 32627698
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of vaginally applied estrogen, testosterone, or polyacrylic acid on vaginal atrophy: a randomized controlled trial.
    Fernandes T; Costa-Paiva LH; Pedro AO; Baccaro LF; Pinto-Neto AM
    Menopause; 2016 Jul; 23(7):792-8. PubMed ID: 27116462
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.